An observational study in Duchenne Muscular Dystrophy, sponsored by Centre d'Investigation Clinique et Technologique 805. Completed at 1 site in France. Open to male participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2020-05-12.
Sponsored by Centre d'Investigation Clinique et Technologique 805 · Observational
Relation between clinical and genetic features and acute digestive events in Duchenne muscular dystrophy patients
Clinical Data of the disease Digestive events (pseudo occlusion, gastrostomy, cholecystectomy) Nutritionnal parameters Genetic of dystrophin (approved genetic nationnal Data base, CHU Cochin, Paris France)
548 studies on the registry are indexed under Muscular Dystrophies; 89 are open to participants now.
This study's enrollment of 200 is above the median of 69 across 179 observational studies indexed under Muscular Dystrophies.
Browse Muscular Dystrophies studies →Centre d'Investigation Clinique et Technologique 805 is the lead sponsor of 74 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Duchenne muscular dystrophy patients
Exclusion Criteria:
Incidence of digestive events
Clinical parameters (yes or no): gastrostomy, bowel occlusion, acute gastric paresia, biliary complication
Time frame: 11 years
Prevalence of digestive events
Clinical parameters (yes or no) : gastrostomy, bowel occlusion, acute gastric paresia, biliary complication
Time frame: 11 years
Risk factors for digestive events (1)
age (years)
Time frame: 11 years
Risk factors for digestive events (2)
pulmonary functional tests (vital capacity in ml/kg)
Time frame: 11 years
Risk factors for digestive events (3)
echocardiography parameters (LVEF: left ventricular ejection fraction in %)
Time frame: 11 years
Risk factors for digestive events (4)
residual dystrophin level (Western blot and/or immunohistochemistry in muscle)
Time frame: 11 years
Risks factors for digestive events (5)
genetic parameters (type of mutation, functional domain of altered dystrophin)
Time frame: 11 years
Nutritional status (1)
Weigh (kg) and height (in m) agregated in BMI (kg/m\^2)
Time frame: 11 years
Nutritional status (2)
albuminemia in g/L
Time frame: 11 years
Plan to share: Undecided — All clinician and biologist involved in the follow-up of these patients
No publications or documents are linked to this record.
This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre d'Investigation Clinique et Technologique 805